Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating alzheimer's disease

Archiv der Pharmazie

Volumn 344, Issue 3, 2011, Pages 139-148

  Pinnen, Francesco ^a   Sozio, Piera ^a   Cacciatore, Ivana ^a   Cornacchia, Catia ^a   Mollica, Adriano ^a   Iannitelli, Antonio ^a   Dâaurizio, Eleonora ^a   Cataldi, Amelia ^a   Zara, Susi ^a   Nasuti, Cinzia ^b   Di Stefano, Antonio ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Alzheimer Disease; Codrug; Glutathione; Ibuprofen

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; GLUTATHIONE; IBUPROFEN; IBUPROFEN PLUS GLUTATHIONE; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONCENTRATION RESPONSE; DRUG CONJUGATION; DRUG STABILITY; DRUG SYNTHESIS; ENZYME ACTIVITY; IN VITRO STUDY; INFLAMMATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; DRUG STABILITY; GLUTATHIONE; IBUPROFEN; MALE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 79952517451     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201000209     Document Type: Article

References (42)

1. E. G. McGeer, P. L. McGeer, Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27, 741-749.
2. H. Y. Zhang, FEBS Lett. 2005, 579, 5260-5264.
3. R. L. Richardson, E. M. Kim, R. A. Shepard, T. Gardiner, J. Cleary, E. O'Hare, Brain Res. 2002, 954, 1-10.
4. T. T. Rohn, R. A. Rissman, E. Head, C. W. Cotman, Drug News Perspect. 2002, 15, 549-557.
5. J. R. Cardinaux, I. Allaman, P. J. Magistretti, Glia 2000, 29, 91-97.
6. L. Stefanis, D. S. Park, L. A. Friedman, J. Neurosci. 1999, 19, 6235-6247.
7. K. L. Davis, Mol. Psychiatry 2002, 7, 925-926.
8. M. T. Heneka, M. K. O'Banion, J. Neuroimmunol. 2007, 184, 69-91.
9. M. Hirohata, K. Ono, H. Naiki, M. Yamada, Neuropharmacology 2005, 49, 1088-1099.
10. M. Hirohata, K. Ono, M. Yamada, Curr. Pharm. Des. 2008, 14, 3280-3294.
11. S. Leuchtenberger, D. Beher, S. Weggen, Curr. Pharm. Des. 2006, 12, 4337-4355.
12. P. I. Moreira, M. S. Santos, C. R. Oliveira, J. C. Shenk, A. Nunomura, M. A. Smith, X. Zhu, G. Perry, CNS Neurol. Disorder Drug Targets 2008, 7, 3-10.
13. M. Sharma, Y. K. Gupta, Eur. Neuropsychopharmacol. 2003, 13, 241-247.
14. D. A. Butterfield, C. B. Pocernich, J. Drake, Drug. Dev. Res. 2002, 56, 428-437.
15. P. P. Zandi, J. C. Anthony, A. S. Khachaturian, S. V. Stone, D. Gustafson, J. T. Tschanz, M. C. Norton, K. A. Welsh-Bohmer, J. C. Breitner, Arch. Neurol. 2004, 61, 82-88.
16. M. C. Morris, D. A. Evans, J. L. Bienias, C. C. Tangney, D. A. Bennett, N. Aggarwal, R. S. Wilson, P. A. Scherr, JAMA 2002, 287, 3230-3237.
17. H. Liu, L. E. Harrell, S. Shenvi, T. Hagen, R. M. Liu, J. Neurosci. Res. 2005, 15 (79), 861-867.
18. A. Meister, M. E. Anderson, Ann. Rev. Biochem. 1983, 52, 711-760.
19. H. Liu, H. Wang, S. Shenvi, T. M. Hagen, R. M. Liu, Ann. N. Y. Acad. Sci. 2004, 1019, 346-349.
20. S. S. More, R. Vince, J. Med. Chem. 2008, 51, 4581-4588.
21. F. Pinnen, I. Cacciatore, C. Cornacchia, P. Sozio, A. Iannitelli, M. Costa, L. Pecci, C. Nasuti, F. Cantalamessa, A. Di Stefano, J. Med. Chem. 2007, 50, 2506-2515.
22. R. Wang, H. Y. Zhang, X. C. Tang, Eur. J. Pharmacol. 2001, 421, 149-156.
23. F. Bonina, M. Lanza, L. Montenegro, G. Puglisi, A. Tomaino, D. Trombetta, F. Castelli, A. Saija, Int. J. Pharm. 1996, 145, 87-94.
24. S. H. Yalkowsky, W. Morzowich, in Drug design (Ed., J. Ariens,), vol. IX, Academic, New York 1980, p. 121.
25. A. Di Stefano, P. Sozio, A. Cocco, A. Iannitelli, E. Santucci, M. Costa, L. Pecci, C. Nasuti, F. Cantalamessa, F. Pinnen, J. Med. Chem. 2006, 49, 1486-1493.
26. A. O. Farghaly, Eur. J. Med. Chem. 1998, 33, 123-131.
27. A. I. Durrani, H. Schwartz, W. Schmid, G. Sontag, J. Pharm. Biomed. Anal. 2007, 45, 694-699.
28. H. T. Chang, L. S. Newa, A. H. Neob, C. W. Gohb, E. R. Browneb, E. C. Y. Chana, Brain Res. 2009, 1251, 80-86.
29. V. Panteleon, I. K. Kostakis, P. Marakos, N. Pouli, I. Andreadou, Bioorg. Med. Chem. Lett. 2008, 18, 5781-5784.
30. G. Melagraki, A. Afantitis, O. Igglessi-Markopoulou, A. Detsi, M. Koufaki, C. Kontogiorgis, D. J. Hadjipavlou-Litina, Eur. J. Med. Chem. 2009, 44, 3020-3026.
31. S. Viirlaid, R. Mahlapuu, K. Kilk, A. Kuznetsov, U. Soomets, J. Järv, Bioorg. Chem. 2009, 37, 126-132.
32. F. Pinnen, I. Cacciatore, C. Cornacchia, P. Sozio, L. S. Cerasa, A. Iannitelli, C. Nasuti, F. Cantalamessa, D. Sekar, R. Gabbianelli, M. L. Falcioni, A. Di Stefano, J. Med. Chem. 2009, 52, 559-563.
33. R. Wang, H. Y. Zhang, X. C. Tang, Eur. J. Pharmacol. 2001, 421, 149-156.
34. C. B. Thompson, Science 1995, 267, 1456-1462.
35. G. Kroemer, Nat. Med. 1997, 3, 614-620.
36. M. Bajda, S. Boryczka, J. Wietrzyk, B. Malawska, Biomed. Chromatogr. 2007, 21, 123-131.
37. P. Sozio, E. D'Aurizio, A. Iannitelli, A. Cataldi, S. Zara, F. Cantalamessa, C. Nasuti, A. Di Stefano, Arch. Pharm. 2010, 343, 133-142.
38. I. Andreadou, A. Tasouli, E. Iliodromitis, A. Tsantili-Kakoulidou, A. Papalois, T. Siatra, D. T. Kremastinos, Eur. J. Pharmacol. 2002, 453, 271-277.
39. G. Burini, R. Coli, Anal. Chim. Acta 2004, 511, 155-158.
40. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, Sydney 1986.
41. R. Morris, J. Neurosci. Methods 1984, 11, 47-60.
42. R. L. Richardson, E. M. Kim, R. A. Shepard, T. Gardiner, J. Cleary, E. O'Hare, Brain Res. 2002, 954, 1-10.